Bar Harbor Trust Services Gilead Sciences, Inc. Transaction History

Bar Harbor Trust Services

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $197,575 - $222,529	-3,423 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$64.88 - $73.64 $7,915 - $8,984	-122 Reduced 3.44%	3,423 $248,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $507 - $554	-8 Reduced 0.23%	3,545 $245,000
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $720 - $821	-12 Reduced 0.34%	3,553 $230,000
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $2,484 - $3,123	-40 Reduced 1.11%	3,565 $225,000
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $5,714 - $6,636	-79 Reduced 2.14%	3,605 $277,000
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $227,008 - $249,701	3,684 New	3,684 $239,000
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $231,798 - $259,675	-3,707 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $84,798 - $98,913	-1,307 Reduced 26.07%	3,707 $263,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $361,559 - $428,546	5,014	5,014 $406,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bar Harbor Trust Services, based on Form 13F filings with the SEC.

Stay updated on Bar Harbor Trust Services with notifications on news.